ClinicalTrials.gov
ClinicalTrials.gov Menu

A Phase I Study of the Safety, Pharmacokinetics, and Anti-Tumor Activity of CUDC-101 in Patients With Advanced Solid Tumors

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00728793
Recruitment Status : Completed
First Posted : August 6, 2008
Last Update Posted : February 21, 2018
Sponsor:
Information provided by (Responsible Party):
Curis, Inc.

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Completed
  Actual Primary Completion Date : April 2010
  Actual Study Completion Date : April 2010